Healthcare provider profile · identity verified

Deana Mercer, MD

Allopathic & Osteopathic Physicians|Orthopaedic Surgery · ALBUQUERQUE, NM · NPI 1275672263

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Deana Mercer, MD received $173,889.60 in general payments during 2025 across 121 reported records.

Skeletal Dynamics Inc accounted for 62.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 18 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$173,889.60

121 reported records · 10 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported companyCanonical companyAmountShareRecordsYear
Skeletal Dynamics Inc Unresolved — no canonical attribution shown $107,974.2862.1%482025
AXOGEN Unresolved — no canonical attribution shown $64,824.4737.3%592025
Checkpoint Surgical, Inc Unresolved — no canonical attribution shown $451.830.3%42025
Kerecis Limited Unresolved — no canonical attribution shown $231.730.1%32025
Endo USA, Inc. Unresolved — no canonical attribution shown $142.470.1%22025
ABBVIE INC. Unresolved — no canonical attribution shown $122.280.1%12025
DePuy Synthes Sales Inc. Unresolved — no canonical attribution shown $65.650.0%12025
ReNerve Ltd Unresolved — no canonical attribution shown $30.260.0%12025
CooperSurgical, Inc. Unresolved — no canonical attribution shown $26.140.0%12025
OsteoCentric Technologies, Inc. Unresolved — no canonical attribution shown $20.490.0%12025

What were the payments for?

Payment categories

CategoryAmountRecords
Education$71,950.0012
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$46,931.2510
Royalty or License$25,687.074
Travel and Lodging$13,995.7915
Food and Beverage$7,750.4975
Consulting Fee$7,575.005

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported productTypeReported companyRelated amount*RecordsYear
Align
Normalized: align
Device Skeletal Dynamics Inc $107,974.28 48 2025
Source payment records
Geminus
Normalized: geminus
Device Skeletal Dynamics Inc $107,974.28 48 2025
Source payment records
IJS
Normalized: ijs
Device Skeletal Dynamics Inc $107,974.28 48 2025
Source payment records
Implate
Normalized: implate
Device Skeletal Dynamics Inc $107,974.28 48 2025
Source payment records
AXOGUARD HA+ NERVE PROTECTOR
Normalized: axoguard ha nerve protector
Device AXOGEN $63,148.19 34 2025
Source payment records
AXOGUARD
Normalized: axoguard
Device AXOGEN $62,923.19 33 2025
Source payment records
AXOGUARD NERVE CAP
Normalized: axoguard nerve cap
Device AXOGEN $62,923.19 33 2025
Source payment records
Checkpoint Stimulators
Normalized: checkpoint stimulators
Device Checkpoint Surgical, Inc $451.83 4 2025
Source payment records
Kerecis GraftGuide
Normalized: kerecis graftguide
Device Kerecis Limited $231.73 3 2025
Source payment records
Kerecis SurgiClose
Normalized: kerecis surgiclose
Device Kerecis Limited $231.73 3 2025
Source payment records
XIAFLEX
Normalized: xiaflex
Biological Endo USA, Inc. $142.47 2 2025
Source payment records
NATRELLE SALINE-FILLED BREAST IMPLANTS
Normalized: natrelle saline filled breast implants
Device ABBVIE INC. $122.28 1 2025
Source payment records
DYNACORD
Normalized: dynacord
Device DePuy Synthes Sales Inc. $65.65 1 2025
Source payment records
DYNATAPE
Normalized: dynatape
Device DePuy Synthes Sales Inc. $65.65 1 2025
Source payment records
TRUESPAN ORTHOCORD
Normalized: truespan orthocord
Device DePuy Synthes Sales Inc. $65.65 1 2025
Source payment records
NervAlign Nerve Cuff
Normalized: nervalign nerve cuff
Device ReNerve Ltd $30.26 1 2025
Source payment records
Cook
Normalized: cook
Device CooperSurgical, Inc. $26.14 1 2025
Source payment records
OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST
Normalized: osteocentric 4 0 x 130mm locking bone screw fastener st
Device OsteoCentric Technologies, Inc. $20.49 1 2025
Source payment records

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

BrandGenericClaimsBeneficiaries
MeloxicamMeloxicam1913

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025 $173,889.60 · 121 records Skeletal Dynamics Inc AXOGUARD, AXOGUARD HA+ NERVE PROTECTOR, AXOGUARD NERVE CAP, Align, Checkpoint Stimulators, Cook, DYNACORD, DYNATAPE, Geminus, IJS, Implate, Kerecis GraftGuide, Kerecis SurgiClose, NATRELLE SALINE-FILLED BREAST IMPLANTS, NervAlign Nerve Cuff, OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST, TRUESPAN ORTHOCORD, XIAFLEX
2024 Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error